Frankfurt-am-Main, Germany

Garima Tiwari


Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Garima Tiwari: Innovator in Multispecific Binding Proteins

Introduction

Garima Tiwari, an accomplished inventor based in Frankfurt-am-Main, Germany, has made significant contributions to the field of biotechnology. With a focus on the development of multispecific binding proteins, her work stands at the forefront of innovative medical research.

Latest Patents

Garima holds a patent for "Multispecific binding proteins with mutant fab domains." This innovative invention includes binding proteins comprising a VL region paired with a VH region, as well as a CH1 region paired with a CL region. The notable aspect of this invention is the incorporation of opposite charged mutations in the VL and VH regions to facilitate pairing. Additionally, the CH1 and CL regions contain mutations that aid in pairing. Furthermore, the patent addresses binding proteins with engineered cysteine residues in the VH/VL pair to enable the formation of disulfide bonds. The patent also encompasses nucleic acids encoding the binding proteins, expression vectors, host cells, pharmaceutical compositions, and methods for administering the described binding proteins or multispecific binding proteins.

Career Highlights

Garima Tiwari currently works with Sanofi, a global healthcare company known for its commitment to innovation in pharmaceuticals and biotechnology. Her dedication to her work has led to meaningful advancements in drug development.

Collaborations

Throughout her career, Garima has collaborated with talented professionals, including her coworkers Marta Amaral and Christian Beil. These partnerships reflect the collective effort and creativity that drive innovation in their field.

Conclusion

Garima Tiwari represents the spirit of innovation in the realm of biotechnology. Her patented work on multispecific binding proteins showcases her commitment to advancing medical research and improving therapeutic options. As she continues her career at Sanofi, the impact of her inventions is sure to resonate within the scientific community and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…